MSB 2.10% $1.17 mesoblast limited

USD573M in retained losses and a less than great 2020!. 2021 a year that cannot get worse, page-12

  1. 2,123 Posts.
    lightbulb Created with Sketch. 568

    Glad you entered into the conversation!

    Here is a list of all Market Announcements from MSB in relation to all their trials since 2009. Have a look at all their announcement titles!

    "success". "positive outcomes" in every single MA covering all manner of things including:

    Rheumatoid Arthritis
    Osteoarthritis
    Disc Repair
    Bone Marrow Transplant
    Lumbar
    Ischemic Stroke
    Pancreas
    Cancer!!!!!

    The list goes on. It's their wording in their announcements. Not mine. So why is everything AWESOME and a SUCCESS when they can't register their agent for any indication?????

    Keep eating it up. Eat at the trough. Believe it to be true!!!

    Does anyone see a pattern here???????????????

    But yes!! of course they've found a subset in their latest CHF trial....BELIEVE!!!!

    Oh, and the ARDS trial taken from the COPD Osirios trial back in 2010......you DO HAVE THOSE COPD TRIAL RESULTS, don't you?????

    Unicorn!!!!!!

    OR IS IT BS?????

    14 May 2009
    11:09am

    11:09am

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    Results Show Significant Heart Function Improvement opens new window

    65KB

    1

    10 Sep 2009
    1:58pm

    1:58pm

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    Successful Repair/Regeneration Damaged Intervertebral Discs opens new window

    63KB

    2

    6 Nov 2009
    11:00am

    11:00am

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    Successful Bone Marrow Regeneration in Cancer Patients opens new window

    61KB

    3

    18 Nov 2009
    12:16pm

    12:16pm

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    Sustained 6 Month Improvement in Heart Muscle Function opens new window

    178KB

    4

    8 Dec 2009
    10:23am

    10:23am

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    Cells Regenerate Pancreas and Reduce Diabetic Glucose Levels opens new window

    64KB

    5

    16 Aug 2010
    11:41am

    11:41am

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    On Track for Phase 3 BMT Trial After Positive FDA Meeting opens new window

    148KB

    6

    21 Oct 2010
    12:02pm

    12:02pm

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    Positive Results From Phase 2 Lumbar Fusion Trial opens new window

    123KB

    7

    10 Jan 2011
    8:41pm

    8:41pm

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    Cardiac Events, Mortality and Hospitalization Reduced opens new window

    160KB

    8

    9 Jun 2011
    11:39am

    11:39am

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    Revascor Increases Blood Supply to Damaged Heart Muscle opens new window

    252KB

    9

    9 Jun 2011
    11:39am

    11:39am

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    Revascor Increases Blood Supply to Damaged Heart Muscle opens new window

    252KB

    10

    10 Nov 2011
    10:27am

    10:27am

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    Positive Results Using Adult Stem Cells for Type 2 Diabetes opens new window

    795KB

    11

    11 Jan 2013
    11:14am

    11:14am

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    Positive Results in Phase 2 Lumbar Spinal Fusion Trial opens new window

    230KB

    12

    22 Apr 2013
    3:02pm

    3:02pm

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    POSITIVE INTERIM RESULTS IN PHASE 2 TRIAL FOR DISC REPAIR opens new window

    386KB

    13

    11 Nov 2013
    11:56am

    11:56am

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    MPCs Induce Functional Recovery in Ischemic Stroke Model opens new window

    99KB

    14

    14 Nov 2013
    12:34pm

    12:34pm

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    Improved Survival in Children with GvHD After Cell Therapy opens new window

    110KB

    15

    19 Nov 2013
    11:21am

    11:21am

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    MPCs Strengthen Cardiac Function in End-Stage Heart Failure opens new window

    253KB

    16

    4 Dec 2013
    12:36pm

    12:36pm

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    Mesoblast Reports Positive Type 2 Diabetes Trial Results opens new window

    335KB

    17

    30 Jan 2014
    10:28am

    10:28am

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    Positive Disc Repair Results Using Mesoblast Stem Cells opens new window

    345KB

    18

    29 Apr 2014
    12:29pm

    12:29pm

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    MESOBLAST PROVIDES UPDATE ON CLINICAL PROGRAMS OF PROCHYMAL opens new window

    153KB

    19

    19 Jun 2014
    1:22pm

    1:22pm

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    no

    Type 2 Diabetes Results Presented by Study Investigators opens new window

    110KB

    20

    16 Feb 2015
    11:39am

    11:39am

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    Results Show Improved Survival in Children with GVHD opens new window

    345KB

    21

    12 May 2015
    12:02pm

    12:02pm

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    Reversed Arterial Dysfunction And Inflammation in RA Model opens new window

    112KB

    22

    9 Jun 2015
    10:29am

    10:29am

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    Positive Diabetic Nephropathy Trial Results opens new window

    128KB

    23

    30 Sep 2015
    12:34pm

    12:34pm

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    MSB Cell Therapy Shows Greatest Effect In Advanced CHF opens new window

    100KB

    24

    16 Feb 2016
    12:39pm

    12:39pm

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    MSB Therapy Shows Benefit In First Cohort Of RA Patients opens new window

    126KB

    25

    1 Apr 2016
    11:36am

    11:36am

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    Mesoblast Cells Show Disease Modifying Effects on Knee OA opens new window

    159KB

    26

    9 Aug 2016
    10:58am

    10:58am

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    Mesoblast P2 Results Show Dose-Related Improvements In RA opens new window

    138KB

    27

    6 Oct 2016
    2:15pm

    2:15pm

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    Mesoblast Phase 2 Diabetic Kidney Disease Results Published opens new window

    116KB

    28

    16 Feb 2017
    10:36am

    10:36am

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    Positive Nine Month RA Results For Mesoblast Cell Therapy opens new window

    161KB

    29

    15 Mar 2017
    1:46pm

    1:46pm

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    Durable Three Year Outcomes in Disc Disease opens new window

    104KB

    30

    10 Apr 2017
    10:45am

    10:45am

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    Successful Interim Analysis in Phase 3 Heart Failure Trial opens new window

    369KB

    31

    16 Aug 2017
    11:56am

    11:56am

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    Positive Results of MSB Therapy in Osteoarthritis Published opens new window

    111KB

    32

    23 Aug 2017
    11:38am

    11:38am

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    Potential For Accelerated Market Entry In Advanced CHF opens new window

    92KB

    33

    22 Feb 2018
    10:48am

    10:48am

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    Primary Endpoint Successfully Achieved in MSB P3 GVHD Trial opens new window

    103KB

    34

    20 Sep 2018
    3:29pm

    3:29pm

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    Day 180 Survival Outcomes In aGvHD Phase 3 Trial opens new window

    97KB

    35

    13 Dec 2018
    1:32pm

    1:32pm

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    no

    Meetings Held With FDA Support MSB's Planned GVHD Filing opens new window

    90KB

    36

    25 Mar 2019
    11:26am

    11:26am

    ·MSB

    MESOBLAST LIMITED

    MESOBLAST LIMITED

    yes

    MSB Licensee Files For Skin Disease Marketing Approval opens new window

    91KB




 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.17
Change
-0.025(2.10%)
Mkt cap ! $1.330B
Open High Low Value Volume
$1.18 $1.22 $1.15 $6.344M 5.404M

Buyers (Bids)

No. Vol. Price($)
1 8683 $1.16
 

Sellers (Offers)

Price($) Vol. No.
$1.17 32999 1
View Market Depth
Last trade - 16.10pm 15/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.